Literature DB >> 1582795

Melatonin increases photoreceptor susceptibility to light-induced damage.

A F Wiechmann1, W K O'Steen.   

Abstract

Melatonin is an indolamine hormone synthesized in the retina and pineal gland. It is thought to act as a paracrine neurohormone in the mammalian retina. Pinealectomy has been shown to protect photoreceptors from light-induced damage, and melatonin treatment has been reported to increase the degree of photoreceptor damage in albino rats. To determine how melatonin influences photoreceptor survival, the effect of melatonin administration on light-induced retinal damage was studied. Melatonin was administered to albino rats by intraperitoneal injections at various times before or after light exposure. The rats were exposed to high-intensity illumination (1600 lux) for 24 hr to induce photodamage, then returned to cyclic lighting for 12 days. After this, they were killed, and their eyes were removed and examined histologically. Measurements of the outer nuclear layer (ONL) thickness were taken at 12 different loci around the circumference of the retinal sections. The animals that received daily melatonin injections (100 micrograms) in the late afternoon (3 hr before lights off) for 1-3 days before photodamage showed an approximate 30% greater reduction compared with sham control animals in ONL thickness in the superior quadrant, the area most susceptible to light damage. Melatonin injections given after the photodamage did not affect ONL thickness. Although retinal susceptibility to light damage varied with time of day, the degree to which melatonin increased the degree of damage appeared unaffected by the time of day. These results suggest that melatonin may be involved in some aspects of photoreceptor sensitivity to light damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582795

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 2.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

Review 3.  The electroretinogram as a method for studying circadian rhythms in the mammalian retina.

Authors:  Morven A Cameron; Alun R Barnard; Robert J Lucas
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 4.  Retinal light damage: mechanisms and protection.

Authors:  Daniel T Organisciak; Dana K Vaughan
Journal:  Prog Retin Eye Res       Date:  2009-12-03       Impact factor: 21.198

5.  Melatonin.

Authors:  J Arendt
Journal:  BMJ       Date:  1996-05-18

6.  Melatonin, Circadian Rhythms, and Sleep.

Authors:  Irina V. Zhdanova; Valter Tucci
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 7.  Circadian organization of the mammalian retina: from gene regulation to physiology and diseases.

Authors:  Douglas G McMahon; P Michael Iuvone; Gianluca Tosini
Journal:  Prog Retin Eye Res       Date:  2013-12-12       Impact factor: 21.198

8.  Dopamine in the Turkey retina-an impact of environmental light, circadian clock, and melatonin.

Authors:  Anna Lorenc-Duda; Małgorzata Berezińska; Anna Urbańska; Krystyna Gołembiowska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2008-10-25       Impact factor: 3.444

Review 9.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

10.  Impact of oral melatonin on the electroretinogram cone response.

Authors:  Anne-Marie Gagné; Konstantin V Danilenko; Serge G Rosolen; Marc Hébert
Journal:  J Circadian Rhythms       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.